Frontiers in Oncology (Feb 2023)

A retrospective case-series of influence of chronic hepatitis B on synchronous liver metastasis of colorectal cancer

  • Lin Zhu,
  • Piqing Gong,
  • Ye Liu,
  • Yunjie Shi,
  • Wenqiang Wang,
  • Wei Zhang,
  • Zhiqian Hu,
  • Zhiqian Hu,
  • Xinxing Li

DOI
https://doi.org/10.3389/fonc.2023.1109464
Journal volume & issue
Vol. 13

Abstract

Read online

Main pointOur retrospective analysis of a large number of cases found in patients with primary colorectal cancer (CRC) carrying positive HBsAg inhibited the occurrence of synchronous liver metastases (SLM). However, liver cirrhosis caused by non-HBV factors promoted the occurrence of SLM.ObjectivesThis study aimed to investigate the effect of HBV on the occurrence of synchronous liver metastases (SLM) of colorectal cancer (CRC).MethodsUnivariate and multivariate analyses were used to analyze the influence of clinical parameters on the occurrence of SLM.ResultsA total of 6, 020 patients with primary CRC were included in our study, of which 449 patients carrying HBsAg(+) accounted for 7.46%. 44 cases of SLM occurred in the HBsAg(+) group, accounting for 9.80%, which was much lower than 13.6% (758/5571) in the HBsAg(-) group (X=5.214, P=0.022). Among CRC patients with HBsAg(-), the incidence of SLM was 24.9% and 14.9% in the group with high APRI and FIB-4 levels, respectively, which were significantly higher than that in the compared groups (12.3% and 12.5%, all P<0.05). Compared with the control group, female patients, late-onset patients, and HBV-infective patients had lower risks of SLM (HR=0.737, 95%CI: 0.614-0.883, P<0.001; HR=0.752, 95%CI: 0.603-0.943, P=0.013; HR=0.682, 95%CI: 0.473-0.961, P=0.034).ConclusionsThe carriage of HBsAg(+) status inhibited the occurrence of SLM from CRC. HBV-causing liver cirrhosis did not further influence the occurrence of SLM, whereas non-HBV-factor cirrhosis promoted the occurrence of SLM. Nevertheless, this still required prospective data validation.

Keywords